Literature DB >> 11481708

Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy.

S Thobois1, E Broussolle, L Toureille, C Vial.   

Abstract

A 71-year-old woman was treated by botulinum toxin (BTX) type A injections for cervical dystonia related to a multiple system atrophy (MSA). A few days later and persisting for the next 4 months, she developed a severe dysphagia, requiring nasogastric feeding. This implicates cautious use of BTX in a case of MSA.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11481708     DOI： 10.1002/mds.1101

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  8 in total

1.  Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis.

Authors:  Takeshi Iwase; Chie Iwase
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-21       Impact factor: 3.117

Review 2.  Current Treatment of Multiple System Atrophy.

Authors:  Sylvia Maaß; Johannes Levin; Günter Höglinger
Journal:  Curr Treat Options Neurol       Date:  2016-12       Impact factor: 3.598

Review 3.  Symptomatic Care in Multiple System Atrophy: State of the Art.

Authors:  Anna Grossauer; Victoria Sidoroff; Beatrice Heim; Klaus Seppi
Journal:  Cerebellum       Date:  2022-05-17       Impact factor: 3.847

Review 4.  Multiple system atrophy.

Authors:  Werner Poewe; Iva Stankovic; Glenda Halliday; Wassilios G Meissner; Gregor K Wenning; Maria Teresa Pellecchia; Klaus Seppi; Jose-Alberto Palma; Horacio Kaufmann
Journal:  Nat Rev Dis Primers       Date:  2022-08-25       Impact factor: 65.038

Review 5.  Recent developments in multiple system atrophy.

Authors:  Gregor K Wenning; Nadia Stefanova
Journal:  J Neurol       Date:  2009-05-27       Impact factor: 4.849

Review 6.  Gastrointestinal dysfunction in the synucleinopathies.

Authors:  Kathryn A Chung; Ronald F Pfeiffer
Journal:  Clin Auton Res       Date:  2020-11-27       Impact factor: 4.435

Review 7.  Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy.

Authors:  Lisa Mészáros; Alana Hoffmann; Jeanette Wihan; Jürgen Winkler
Journal:  Int J Mol Sci       Date:  2020-04-16       Impact factor: 5.923

Review 8.  Current Management and Emerging Therapies in Multiple System Atrophy.

Authors:  Matthew R Burns; Nikolaus R McFarland
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 6.088
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.